UNSPSC 51283112: Gramicidin

This classification denotes an anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5IE62321P4. European Medicines Agency schedules Gramicidin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02403MIG. Gramicidin generally arises in the molecular formula C60H92N12O10.

UNSPSC 51283112 Gramicidin is a Commodity code that covers pharmaceutical active ingredients and antimicrobial compounds, though recent state and local opportunities tagged under this code reflect broader pharmaceutical procurement including finished-dose antibiotics and public health supplies rather than gramicidin specifically. State and local governments use this code to solicit antimicrobial pharmaceuticals, public health emergency supplies, and related medical products through cooperative purchasing vehicles and competitive bidding. Issuing bodies soliciting under the code include state health departments and county health authorities pursuing supplies for community health programs and emergency response.

Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium in August 2026 for antibiotic tablets (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg) with a 12-month initial term and two one-year renewal options. Seminole County, Florida issued an IFB in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term and one-year renewal option. Recent activity concentrates in Florida and Illinois. The code shows limited recent state and local solicitation volume; the opportunities present do not consistently reflect gramicidin procurement as named in the code taxonomy.